Skyrizi vs Zoryve

Skyrizi: An injected biologic for moderate to severe plaque psoriasis. It blocks interleukin-23, a signal that sits high up in the psoriasis chain, and after two starting doses it is given about four times a year. Zoryve: A once-daily steroid-free cream for psoriasis, eczema and seborrheic dermatitis. It has no boxed warning and no limit on how long or how much you use it, which is unusual.

Reviewed by Dr. Schwarz, Board-Certified Dermatologist
Skyrizi shown in recognizable white injection pen with blue and turquoise accents.Representative medication packaging labelled Zoryve, lying sideways on a white background.

Which one is right for you?

Choose Skyrizi if…

Choose for moderate to severe psoriasis when you want high clearance with only about four injections a year.

  • Moderate to severe plaque or scalp psoriasis
  • You want infrequent injections
  • No active TB

Choose Zoryve if…

Choose for psoriasis, eczema or seborrheic dermatitis when you want a once-daily non-steroid with no limit on time or area.

  • Psoriasis in folds or on the face
  • Seborrheic dermatitis of scalp or face
  • You want to avoid steroid side effects
Fine together

Can you take them together?

Zoryve can be used on remaining plaques while on Skyrizi, including the face and folds.

At a glance

● Skyrizi
● Zoryve
Type
Biologic injection (risankizumab, IL-23 blocker)
Topical PDE4 inhibitor (roflumilast)
What it does
Blocks IL-23, high up in the psoriasis chain
Calms inflammation without a steroid
Best for
Moderate to severe plaque psoriasis and psoriatic arthritis
Psoriasis, eczema and seborrheic dermatitis
Prescription
Yes
Yes
Form
Injection under the skin
Cream or foam, 0.15% or 0.3%
How often
Weeks 0 and 4, then every 12 weeks
Once daily
Course length
Ongoing
No time limit
Time to results
16 weeks
4–8 weeks
Main side effect
Colds; injection-site reactions
Rarely any; mild diarrhea or headache
Blood tests
TB test before starting
None
Pregnancy
Check with your clinician
Check with your clinician
Cost
High; no generic
High; brand only

What it treats

Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.

Evidence level
Skyrizi
Zoryve
Strong evidenceMost established uses
Two thick, sharply bordered plaques on a knee on fair light skin. They are salmon-pink to red with loose silvery-white scale on top.

Psoriasis

Clears or nearly clears skin in most patients.
Psoriatic Arthritis on light skin.

Psoriatic Arthritis

Reduces joint symptoms.
Parted hair on fair scalp skin showing a raised salmon-pink plaque topped with dry silvery-white scale, with a sharply drawn border against normal skin.

Scalp Psoriasis

Improves scalp plaques.
Two thick, sharply bordered plaques on a knee on fair light skin. They are salmon-pink to red with loose silvery-white scale on top.

Psoriasis

Clears plaques, including in folds.
Salmon-pink patches with fine greasy yellowish scale in the crease beside the nose and through the eyebrow on fair skin, with soft edges that fade into normal skin.

Seborrheic Dermatitis

Foam reduces scalp and face scale.
Moderate evidenceSome supportive research
—
Extreme close-up of light skin in an active eczema flare, too close to tell which part of the body it is. Blotchy pink-red inflammation covers the whole frame with no clear edge, with small raised bumps, fine dry scale and a few fresh scratch marks.

Eczema

Reduces itch and redness.
Little evidence
An inflamed lump in the armpit on fair skin. The skin over it is swollen, shiny and red, with a pair of small blackhead-like openings in the skin beside it.

Hidradenitis Suppurativa

Trials were disappointing.
Redness and fine superficial vessels across a light-skinned cheek and nose.

Rosacea

Not studied enough.
Not effective
Extreme close-up of light skin in an active eczema flare, too close to tell which part of the body it is. Blotchy pink-red inflammation covers the whole frame with no clear edge, with small raised bumps, fine dry scale and a few fresh scratch marks.

Eczema

Doesn't target eczema inflammation.
Inflamed acne on light skin. The spots sit in a patch of pink, and the ring of redness around each one is easy to see. A few have a yellow-white head, and the skin between them is dry and flaking.

Acne

No role in acne.
How it works

Skyrizi

Skyrizi. Risankizumab interrupts the IL-23 psoriasis pathway. 1. Blocks IL-23: Binds this immune messenger before it reaches its receptor. 2. Turns down inflammatory T cells: Reduces signals that keep the psoriasis cycle active. 3. Helps plaques clear: Excess skin buildup and inflammation gradually decrease.
Open full-size diagram
Diagram explanation and sources

Blocks IL-23: Binds this immune messenger before it reaches its receptor. Turns down inflammatory T cells: Reduces signals that keep the psoriasis cycle active. Helps plaques clear: Excess skin buildup and inflammation gradually decrease.

Risankizumab selectively targets the p19 subunit of IL-23, not IL-12. The T-cell and skin changes are a simplified downstream interpretation.

Source 1

Zoryve

Zoryve. Roflumilast turns down inflammation inside skin. 1. Blocks PDE4: Inhibits an enzyme that breaks down cAMP. 2. Raises cAMP inside cells: Preserves a signal involved in regulating inflammation. 3. Helps inflamed skin settle: Redness, scaling, and itch can improve.
Open full-size diagram
Diagram explanation and sources

Blocks PDE4: Inhibits an enzyme that breaks down cAMP. Raises cAMP inside cells: Preserves a signal involved in regulating inflammation. Helps inflamed skin settle: Redness, scaling, and itch can improve.

PDE4 inhibition and increased intracellular cAMP are established. The exact link to clinical improvement is not fully defined; this is a simplified overview, not every downstream pathway.

Source 1

How you take it

Treatment plan

Two starting doses close together, then a long steady interval. Not adjusted for body weight.

Starting dose: 150 mg as one injection.

Second dose: 150 mg, four weeks after the first.

Usual dose: 150 mg every 12 weeks — about four injections a year after the first year.

If it stops working: There is no approved higher dose or shorter interval for psoriasis. Losing response means reviewing the diagnosis, not injecting more often.

How long: Long term, with no set end point, while it works and is tolerated.

When to Apply: Once a day, at a time you will remember. A thin layer over the affected skin, rubbed in. It can go on the face, eyelids, armpits, groin and under the breasts. Moisturizer and sunscreen can go on top once it has absorbed. For the foam, part the hair and apply to the scalp rather than the hair.

How to Start: Once daily from day one, on every affected area. No build-up period, no strength to work through. The common mistake is treating only the worst patches, which makes the result look worse than it is.

If It Irritates: Stinging or mild burning where you apply it settles within a week or two, and moisturizing beforehand helps. Loose stools, headache or feeling slightly sick in the first weeks is a known, usually mild effect of the drug — tell your doctor if it does not pass.

If It's Not Working: Give it 8 weeks of daily use, though itch often eases much sooner. If plaques are unchanged at 8 weeks, the options are a strong steroid for the thickest areas while keeping roflumilast on the rest, adding a vitamin D cream, or moving to light treatment or a systemic medicine. Twice a day does not help.

When to take it

Any time of day. The calendar matters more here than with a weekly drug. Twelve weeks is long enough that people lose track, so put every dose date in your phone and book the next reminder the day you inject.

Take it out of the fridge 15 to 30 minutes before and let it warm on the counter. Cold liquid stings. No hot water, no microwave.

Inject into the front of the thigh or the belly, at least two inches from the navel. The back of the upper arm works if someone else is doing it. Rotate the site, avoid skin that is bruised, tender, hard or scarred, and never inject through a plaque. Ask for training before the first dose. Used devices go in a sharps container.

Not covered in this guide yet
If you miss a dose

Inject as soon as you remember, then count twelve weeks from that day. If it has been much longer than twelve weeks, call the prescriber first so the schedule can be reset.

Not covered in this guide yet
Monitoring

Everyone is screened for tuberculosis before the first dose — a skin test or TB blood test, plus a chest X-ray if that is positive. Dormant TB is treated first. This class probably carries less TB risk than the TNF blockers, but screening is not optional.

Hepatitis B and C are usually checked at the same time.

After that there is no fixed blood test schedule. Risankizumab does not need the regular liver and blood count testing methotrexate does. Monitoring is clinical: the skin, whether infections are more frequent, whether the dose dates are kept. TB testing is repeated yearly or by exposure risk.

There is no boxed warning. The most common side effects reported are upper respiratory infections, headache, tiredness, fungal skin infections and injection site reactions. Serious allergic reactions are rare but are why the first dose is often given with someone trained nearby.

No routine blood tests, no boxed warning, no limit on how much body surface you treat, no maximum duration.

What is worth watching has nothing to do with skin. The oral form causes diarrhea, nausea, appetite loss and weight loss in a meaningful number of people, and has been linked to low mood and, rarely, suicidal thoughts. The cream and foam give much lower blood levels, so these are far less common — but they are on the label and your doctor will ask. If you lose weight without trying, or your mood drops, say so.

Otherwise monitoring is a review of whether it is working, around 8 weeks at first. Your doctor will check your history for liver problems, since severe liver impairment rules it out.

When you’ll see results

Approximate windows, not promises.

● Skyrizi
● Zoryve
First few minutes

First few minutesThe injection: A sharp sting for a few seconds, then redness or a small welt. Settles within a day or two.

First few minutesApplying it: Once a day. Possible stinging where you apply it, which usually settles.

Weeks 1 to 4

Weeks 1 to 4Starting: Itch settles first. Scale lifts and plaques thin.

Weeks 4 to 16

Weeks 4 to 16Working: Most of the change happens here, from the second dose on. Plaques flatten and redness fades from the middle out, often leaving a paler or darker mark.

Week 16

Week 16Judge it here: Most people reached 90 percent clearer skin, and many were clear or nearly clear. Joints improve on the same timeline.

3 to 6 months

3 to 6 monthsScalp, palms and soles: Slower than the trunk and limbs.

6 to 12 months

6 to 12 monthsNails: Last to change, because a nail takes months to grow out.

Between doses

Between dosesSteady state: Most people notice no dip. If plaques reliably return in the last few weeks, say so.

Week 1

Week 1Adjusting: A few people get diarrhea, headache or mild nausea. These come from the drug rather than the skin, and are far less common with the cream than the oral version.

Weeks 1 to 2

Weeks 1 to 2First change: Itch improves first. In seborrheic dermatitis, flaking and redness often start easing here too.

Weeks 4 to 8

Weeks 4 to 8Working: Plaques flatten, scale drops away and redness fades. Week 8 is the fair point to judge plaque psoriasis; eczema and seborrheic dermatitis declare themselves around four weeks. Thinner plaques respond faster.

Folds, face and eyelids

Folds, face and eyelidsWhere it stands out: These sites absorb steroids quickly and thin fast, so a once-daily option with no time limit changes how they are managed.

After clearing

After clearingHolding: No thinning, so no reason to stop once skin is clear. Many people continue daily; some drop to a few times a week.

Side effects

Sorted by what to do about them.

Skyrizi

Zoryve

Common
Common
  • Colds and upper respiratory infections
  • Headache, tiredness
  • Injection-site reactions
Common
  • Rarely any
  • Mild diarrhea, headache
Tell your doctor
Tell your doctor
  • Persistent cough or night sweats
Tell your doctor
  • Application-site pain
Stop and get care
Stop and get care
  • Fever with serious infection
  • Swelling of face or throat
Stop and get care
  • Swelling or trouble breathing

Safety and who should avoid it

Pregnancy
Use care
Discuss with your clinician.
Ask first
Discuss with your clinician.
Breastfeeding
Use care
Discuss with your clinician.
Ask first
Discuss with your clinician.
Children
Not used
Adults for psoriasis.
2 and older
Approved from 2 for some uses.
Monitoring
Sometimes
TB test before starting; liver tests for Crohn's dosing.
None
Review at 8 weeks.
Key interactions
Check
Avoid live vaccines.
Check
Some enzyme inhibitors and oral roflumilast.
Other cautions
Avoid
Active TB or serious infection.
Avoid
Moderate to severe liver disease.

Cost and getting it

Getting it and cost

The list price runs to tens of thousands of dollars a year. Almost nobody pays that; what you pay depends on your plan.

It is brand only — no generic, no biosimilar — so there is no cheaper equivalent to switch to. That is a real difference from adalimumab.

Prior authorization is close to universal. Most plans require documented failure of something cheaper first — phototherapy, methotrexate, sometimes another biologic. Denials are usually about missing records rather than the drug, and appeals succeed reasonably often when the history is documented.

Manufacturer copay cards can cut the cost to very little with commercial insurance. By law they cannot be used with Medicare or Medicaid. For those plans, or no insurance, the manufacturer's patient assistance program and independent foundations are the usual routes. Terms change often.

One practical note: because doses are twelve weeks apart, a change of insurance or a formulary switch in January can land in the middle of a dosing gap. Check coverage before the next dose is due, not the week it is.

This is the main reason people do not end up on it. Roflumilast is brand only with no generic, and a tube runs to several hundred dollars or more. Generic steroid creams cost a small fraction of that.

A prior authorization is close to routine. Most plans want to see that a topical steroid was tried and either failed or is not appropriate — the fold, face and eyelid argument usually succeeds, because those are exactly the places long-term steroid use causes harm. Some plans also want a vitamin D cream tried first. Denials are common on the first attempt and often overturned on appeal, so push back.

The manufacturer runs a copay program that can cut the cost substantially with commercial insurance, plus patient assistance for people who qualify. Terms change often. People on government insurance generally cannot use copay cards, which is a real gap.

One practical note: cost is per tube and psoriasis treatment is open-ended, so ask about the largest tube your plan will cover — the price per gram is usually better.

When you stop

Comes back?
Psoriasis returns slowly, often over many months.
Plaques and scale return gradually after stopping.
Taper needed?
No.
No.
After the last dose
Restarting usually works again.
Restart if it returns.

Common questions

Skyrizi:What does biologic mean?

A large protein grown in living cells rather than a chemical made in a factory. That is why it is injected, and why it lives in the fridge.

Skyrizi:Really only four injections a year?

After the first two doses, four weeks apart, yes. The drug stays in the body long enough that the gap can be twelve weeks.

Skyrizi:Does the injection hurt?

A few seconds of stinging. Letting it warm to room temperature first makes a noticeable difference.

Skyrizi:Do I need blood tests while I am on it?

Tuberculosis and hepatitis before you start, and TB testing often repeated yearly. Beyond that, no routine schedule.

Skyrizi:What happens if I am late with a dose?

Inject when you remember and count twelve weeks from that day. If you are weeks or months late, call first.

Skyrizi:Can I have vaccines?

Yes, apart from live ones. The flu shot, COVID vaccines and Shingrix are not live. Have any live ones before starting.

Zoryve:Is roflumilast a steroid?

No. It blocks an enzyme called PDE4 inside inflammatory cells. It does not thin skin, which is why it can go on the face, eyelids and folds without a time limit.

Zoryve:How long can I use it?

There is no fixed maximum. The rule about stopping after a few weeks comes from steroid creams. Long-term daily use with regular review is normal.

Zoryve:Why is it once a day when most creams are twice?

Once daily is what the trials tested. Twice does not clear skin faster and makes stomach side effects more likely.

Zoryve:Will it upset my stomach?

Usually not. Diarrhea, nausea and headache are listed because they can happen, and are common with the oral version used for lung disease. Blood levels from the cream and foam are much lower.

Zoryve:What is the difference between the cream and the foam?

The drug is the same. The foam lets it spread through hair and over the scalp, and it is the form used for seborrheic dermatitis. The 0.3% cream is for psoriasis and the 0.15% cream for eczema.

Zoryve:Why is there still a mark where the plaque was?

Clearing inflammation often leaves a dark or pale patch. Not active disease, and it fades over months. It shows up more on deeper skin tones.

Zoryve:Can I use it with a steroid cream?

A common approach — a strong steroid for the thickest patches, roflumilast for the face, folds and the rest. Plan it with your doctor rather than layering both on one spot.

Dermapedia on YouTube